- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07458152
Comparison of Wrist Splint Positions in Carpal Tunnel Syndrome
March 10, 2026 updated by: Fatma Merih Akpınar, Istanbul University
Evaluation of the Effectiveness of Splint Use in Different Wrist Positions in the Treatment of Carpal Tunnel Syndrome: A Single-Blind, Randomized, Controlled Trial
Carpal tunnel syndrome (CTS) is the most common nerve compression syndrome.
It develops as a result of the compression of the median nerve while passing through the osteofibrous structure of the carpal tunnel located at the wrist.
Sensory symptoms are the most prominent feature of CTS.
These symptoms are observed as pain, paresthesia, and decreased sensory sensitivity.
As motor symptoms, thumb abduction and opposition are primarily affected.
In advanced cases, atrophy develops in the thenar muscles.
Patients may describe weakness as difficulty in writing, opening jars, buttoning, or grasping objects.
The diagnosis is made by fulfilling both clinical and electrophysiological diagnostic criteria.
CTS has both conservative and surgical treatment options.
Conservative treatment includes splinting, physical therapy modalities, and injection options, and it is preferred in mild and moderate cases.
Among non-surgical treatment options, splint use is a commonly applied intervention; however, there is no consensus regarding its effectiveness, the optimal wrist position during use, or the duration and frequency of splint application.
A total of 108 hands from patients aged 18 to 55 years diagnosed with CTS will be included in this study and randomized into three groups.
All groups will be given an education and exercise program.
The first group will use a wrist splint fixed at 15° flexion; the second group at neutral position; and the third group at 20° extension, to be worn only at night for eight weeks.
Patients will be evaluated before treatment, immediately after treatment, and two months after the end of treatment using measures of pain- numbness severity, functional status, motor and sensory examination findings, and nerve conduction studies.
What makes this study unique is that it evaluates the effects of splints that stabilize the wrist at different angles together with electrophysiological findings.
A review of the literature shows that while some studies have examined and compared the effects of splints fixed at different wrist angles on symptoms, functional status, and physical examination findings, there is no study that evaluates these effects along with electrophysiological findings.
Therefore, this study, which will compare the effectiveness of splints at different angles, is expected to contribute to the literature.
The expected outcomes of this research are that one or more types of splints used in the conservative treatment of CTS will provide improvements in symptom severity, functional status, sensory and motor physical examination findings, and electrophysiological evaluation findings at the end of treatment.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
108
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosis of mild to moderate carpal tunnel syndrome confirmed by electrophysiological studies performed within the last year.
- Clinical findings consistent with carpal tunnel syndrome.
- Age between 18 and 65 years.
Exclusion Criteria:
- <18 years or >65 years
- Thenar atrophy
- Surgery history for CTS
- Steroid injection for CTS
- Physical treatment for CTS in the last 6 months
- Cervical radiculopathy
- Tenosynovitis
- Peripheral polyneuropathy
- Another compressive neuropathy in the ipsilateral upper extremity
- History of trauma/fracture to the hand-wrist region
- Pregnancy
- Metabolic disease
- Rheumatic/autoimmune disease
- Kidney failure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 15° Flexion Wrist Splint Group
|
Participants will wear wrist splint fixed at 15° of wrist flexion during nighttime only for eight weeks.
All participants will also receive a standardized education.
All participants will also receive a standardized exercise program.
|
|
Active Comparator: Neutral Wrist Splint Group
|
All participants will also receive a standardized education.
All participants will also receive a standardized exercise program.
Participants will wear a wrist splint maintaining the wrist in a neutral position during nighttime only for eight weeks.
|
|
Active Comparator: 20° Extension Wrist Splint Group
|
All participants will also receive a standardized education.
All participants will also receive a standardized exercise program.
Participants will wear a wrist splint fixed at 20° of wrist extension during nighttime only for eight weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nerve Conduction Study (NCS)
Time Frame: Baseline and sixteen week of intervention
|
Median motor distal latency and conduction velocity and second finger recorded median sensory distal latency and conduction velocity will be measured in all individuals.
In addition to routine conduction examinations, fourth finger recorded median-ulnar peak latency comparison examinations will also be made.
|
Baseline and sixteen week of intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Pain Scale (VAS)
Time Frame: Baseline, eight week of intervention, sixteen week of intervention
|
Pain and numbness at rest, at night, and during movement will be assessed using a visual analog scale (VAS) ranging from 0 to 10, where 0 represents "no pain" and 10 represents "unbearable pain."
|
Baseline, eight week of intervention, sixteen week of intervention
|
|
Boston Carpal Tunnel Syndrome Questionnaire (BCTSQ)
Time Frame: Baseline, eight week of intervention, sixteen week of intervention
|
BCTSQ assesses the severity of symptoms and functional status in patients with carpal tunnel syndrome.
The symptom severity scale assesses the symptoms with respect to severity, frequency, time and type.
The scale consists of 11 questions with multiple-choice responses, scored from 1 point (mildest) to 5 points (most severe).
The overall symptom severity score is calculated as the mean of the scores for the eleven individual items.
The functional status scale assesses the affect of the carpal tunnel syndrome on daily living.
The scale consists of 8 questions with multiple choice responses, scored from 1 point (no difficulty with the activity) to 5 points (can not perform the activity at all).
The overall score for functional status was calculated as the mean of all eight.
Thus, a higher symptom severity or functional status score indicates worse symptoms or dysfunction.
|
Baseline, eight week of intervention, sixteen week of intervention
|
|
Semmes Weinstein Monofilament Test (SWMT)
Time Frame: Baseline, eight week of intervention, sixteen week of intervention
|
Using 20 pieces of SWMT, sensitive touch threshold sensitivity of each hand will be tested.
The examiner and the subject will seated opposite each other.
Both arms of the subject will arranged on a table in supination, with palm upwards.
The patient will be instructed to close their eyes.
The monofilaments will be touched fingertips of first three fingers on the radial side of both hands, with enough force to bend the monofilament for 1.5 seconds.
The thinnest monofilament numbers that the patient feels being touched will be recorded.
|
Baseline, eight week of intervention, sixteen week of intervention
|
|
Two Point Discrimination Test (TPDT)
Time Frame: Baseline, eight week of intervention, sixteen week of intervention
|
Two point discrimination sense will be evaluated statically using an esthesiometer.
The examiner and the subject will seated opposite each other.
Both arms of the subject will arranged on a table in supination, with palm upwards.
The patient will be instructed to close their eyes.
The contact time of the discriminator with the fingertip ranged from 3 to 5 seconds.
The evaluation will be started by touching a single point on the first three fingertips on the radial side of both hands.
Each three fingers will be evaluated separately and the distance between the two touched points will be increased by 1mm in each measurement.
The smallest values will be taken in millimeters which the patient feels the two points as two separate points on the tested hand will be noted and the the average value written as the result.
|
Baseline, eight week of intervention, sixteen week of intervention
|
|
Hand Grip Force
Time Frame: Baseline, eight week of intervention, sixteen week of intervention
|
The squeeze force will be measured while the patients are sitting, with the elbow in 90 degrees flexion and they will be asked to make a maximally voluntary grip.
Measurements will be made three times in a row on both hands and the average of the three measurements will be noted as a result in kilogram (kg).
|
Baseline, eight week of intervention, sixteen week of intervention
|
|
Thumb and Forefinger Pinch Force
Time Frame: Baseline, eight week of intervention, sixteen week of intervention
|
The pinch force with thumb and forefinger will be measured while the patients are sitting, with the elbow in 90 degrees flexion and they will be asked to make a maximally voluntary grip.The pinch force will be measured as kg with a pinch dynamometer, and the average of the three measurements will be noted as a result.
|
Baseline, eight week of intervention, sixteen week of intervention
|
|
Manuel Muscle Testing of M. Abductor Pollicis Brevis
Time Frame: Baseline, eight week of intervention, sixteen week of intervention
|
Manual muscle testing will be evaluated in 5 grades.
No visible or palpable muscle contraction 0, visible or palpable muscle contraction without motion grade 1, muscle contraction that creates movement at full of range of motion when gravity is eliminated grade 2, muscle contraction that creates movement at full of range of motion against gravity grade 3, muscle contraction that creates movement at full of range of motion against gravity and moderate resistance grade 4, muscle contraction that creates movement through the entire range of motion of the joint against gravity and full resistance will be considered as the grade 5
|
Baseline, eight week of intervention, sixteen week of intervention
|
|
Vibration Sensation
Time Frame: Baseline, eight week of intervention, sixteen week of intervention
|
Vibration sense was tested with tuning fork.
The examiner and the subject will be seated opposite each other.
Both arms of the subject will be arranged on a table in supination, with palm upwards.
The patient will be instructed to close their eyes.
Vibrating tuning fork will be placed on the palmar aspect of the distal phalanx of first three fingers on the radial side of both hands, The patient will be asked to say 'done' when the vibration in his hand was over.
The average of three measurements will be noted as a result in seconds.
|
Baseline, eight week of intervention, sixteen week of intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 1, 2026
Primary Completion (Estimated)
January 1, 2029
Study Completion (Estimated)
January 1, 2029
Study Registration Dates
First Submitted
March 3, 2026
First Submitted That Met QC Criteria
March 3, 2026
First Posted (Actual)
March 9, 2026
Study Record Updates
Last Update Posted (Actual)
March 12, 2026
Last Update Submitted That Met QC Criteria
March 10, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Nervous System Diseases
- Wounds and Injuries
- Neuromuscular Diseases
- Mononeuropathies
- Nerve Compression Syndromes
- Cumulative Trauma Disorders
- Sprains and Strains
- Peripheral Nervous System Diseases
- Carpal Tunnel Syndrome
- Median Neuropathy
- Motor Activity
- Movement
- Musculoskeletal Physiological Phenomena
- Musculoskeletal and Neural Physiological Phenomena
- Socioeconomic Factors
- Population Characteristics
- Exercise
- Educational Status
Other Study ID Numbers
- E-29624016-050.99-3310018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Neuropathies
-
Centre Hospitalier Universitaire de NiceNot yet recruitingHereditary and Inflammatory Peripheral NeuropathiesFrance
-
The University of Texas Health Science Center at...CompletedPeripheral NeuropathiesUnited States
-
University of Milano BicoccaRecruitingPeripheral NeuropathiesItaly
-
Dana-Farber Cancer InstituteRecruitingNeuropathy | Peripheral Neuropathies | Peripheral Neuropathy Due to Chemotherapy | Chemotherapy Induced Peripheral Neuropathy (CIPN)United States
-
Tools4PatientCompletedPeripheral NeuropathiesFrance
-
Tools4PatientInternational Drug Development InstituteCompletedOsteoarthritis | Peripheral NeuropathiesFrance, Belgium
-
Admin CICRecruitingPeripheral Neuropathies | Environmental Risk Factor | Lead Neuropathy | Mercury Neuropathy | BitaFrench Guiana
-
National Center for Complementary and Integrative...CompletedHIV Infections | Peripheral NeuropathiesUnited States
-
University of LahoreCompleted
-
Azienda di Servizi alla Persona di PaviaNot yet recruitingDiabetic Neuropathies, Painful | Neuropathic Pain Management | Palmitoylethanolamide
Clinical Trials on Flexion Splint
-
University Hospital Inselspital, BerneRecruiting
-
Logan College of ChiropracticUnknown
-
University of AlbertaCompleted
-
University of Toronto Orthopaedic Sports MedicineArthroscopy Association of North AmericaUnknownAnterior Cruciate Ligament InjuryCanada
-
Umraniye Education and Research HospitalTerminatedEmergencies | Orthopedics | Radial Head SubluxationTurkey
-
Gaziantep Islam Science and Technology UniversityCompleted
-
Asan Medical CenterCompleted
-
Oxford University Hospitals NHS TrustUniversity of OxfordTerminatedOsteoarthritis, Knee
-
Ain Shams UniversityActive, not recruitingBadly Broken Maxillary Premolars Indicated for ExtractionEgypt
-
St Helens & Knowsley Teaching Hospitals NHS TrustWithdrawn